In January 2018, a class-action lawsuit was filed against Enzymatic Therapy for allegedly deceptively advertising that Ultra Liver Cleanse is able to “Remove Toxins” and cleanse and rejuvenate the liver when, according to plaintiffs, the product cannot detoxify, cleanse, or rejuvenate the liver. Plaintiffs also claim that the company misleads consumers by communicating that the product has “drug-like effects” when it is not an FDA approved drug. (Jocelyn et al v. Enzymatic Therapy, LLC, Case No. 18-cv-564, E.D.N.Y.)

The Latest


Show More